Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04767061 · ClinicalTrials.gov registry record · Phase 4
Impact of Beta-blockers on Physical Function in HFpEF
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT04767061 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 9 participants.
The verdict
NCT04767061, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the impact of beta-blockers on physical function in older adults with heart failure. We will achieve this objective by conducting N-of-1 trials. N-of-1 trials are personalized experiments that test different treatment options in an individual patient.
Interventions
- DRUG Beta blockers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2023-04-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04767061
The ClinicalTrials.gov registry entry for NCT04767061 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beta blockers is the first listed.
NCT04767061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04767061 about?
NCT04767061 is a clinical study titled "Impact of Beta-blockers on Physical Function in HFpEF". The purpose of this study is to understand the impact of beta-blockers on physical function in older adults with heart failure. We will achieve this objective by conducting N-of-1 trials. N-of-1 trials are personalized experiments that test different treatment options in an individual patient.
What is the current status of trial NCT04767061?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2021-04-01. Estimated completion is 2023-04-28.
What interventions are being tested in trial NCT04767061?
The interventions under investigation include: Beta blockers (DRUG).
Who is sponsoring clinical trial NCT04767061?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.